Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Maria Zalesska-Kręcicka is active.

Publication


Featured researches published by Maria Zalesska-Kręcicka.


Oral Oncology | 1999

Epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and Ki-67 antigen in laryngeal epithelial lesions

Tomasz Kręcicki; Michal Jelen; Maria Zalesska-Kręcicka; Jerzy Rak; Teresa Szkudlarek; Joanna Jelen-Krzeszewska

The epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and Ki-67 immunostaining in paraffin sections from 154 cases of laryngeal squamous cell carcinoma, 25 specimens of normal and hyperplastic laryngeal epithelium, and 21 preneoplastic lesions was examined. The difference of EGFR expression and PCNA score between laryngeal cancer and dysplastic lesions vs normal and hyperplastic epithelium was significant. There was significant difference in Ki-67 score between malignant vs premalignant lesions and normal and hyperplastic epithelium. There was significant correlation between PCNA score and histopathological grading of the tumour. The highest PCNA expression was detected in stage G3. Our findings have shown that PCNA and Ki-67 staining can be used as a marker of cell proliferative activity in laryngeal epithelial lesions. EGFR, PCNA and Ki-67 expression correlate with severity of laryngeal lesions. PCNA immunostaining can aid in estimating the histological grade of malignant lesions.


Acta Oto-laryngologica | 2002

Laryngeal Manifestations of Gastroesophageal Reflux Disease in Children

Maria Zalesska-Kręcicka; Tomasz Krecicki; B. Iwanczak; A. Blitek; M. Horobiowska

Although the association between gastroesophageal reflux disease (GERD) and laryngeal disorders in adults is well established there is still a lack of information concerning the true extent of the laryngeal complications of GERD in children. The aim of this study was to determine the laryngeal status of children with diagnosed GERD. We sought to identify the initial appearance of their larynges and then to determine the clinical response to antireflux therapy. GERD was recognized in 90/100 children examined. Using 24-h pH monitoring we found that most of the patients experienced episodes of gastroesophageal reflux during the daytime when they were in an upright position. The hallmark of GERD affecting the larynx in our group was posterior laryngitis, which is characterized by erythema of the mucous membrane overlying the arytenoid cartilages and the posterior mucosal wall of the glottis. The findings regarding the effectiveness of therapy were that, in children with severe laryngeal alterations, voice quality improved significantly after 12 weeks of antireflux treatment ( p < 0.001) and laryngeal status was significantly better after 6 weeks of treatment ( p < 0.001). This study provides evidence that gastroesophageal reflux in children is the underlying cause of inflammatory and morphological lesions, and that antireflux treatment is effective in reducing or eliminating these lesions.


Oral Oncology | 1998

Laryngeal cancer in Lower Silesia: descriptive analysis of 501 cases.

Tomasz Kręcicki; Maria Zalesska-Kręcicka; M Jagas; K Szajowski; J Rak

This paper presents a descriptive analysis of 501 cases of laryngeal cancer. The patients were classified according to their age, sex, primary tumour localisation and stage. There were 448 males and 53 females, with a male-to-female ratio of 8.5:1. The peak incidence of cancer was detected in the 6th and 7th decades of age. The most common primary tumour localisation was the glottis. Three-hundred-and-forty patients presented at advanced tumour stages (T3/T4). The proportion of patients presenting matastatic neck nodes was 29.3% and the incidence of metastatic lymph nodes increased with increasing T stage. Histopathological analysis revealed that 98% of tumours were squamous cell carcinomas. There were 125 well-differentiated, 235 moderately differentiated and 133 poorly differentiated carcinomas. Among other tumours, there was 1 adenoid squamous cell carcinoma, 1 giant cell carcinoma, 1 adenoma pleomorphicum, 1 adenoid cystic carcinoma (cylindroma), 1 haemangiopericytoma, 1 verrucous cell carcinoma, 1 lymphoepithelioma and 1 granular cell tumour.


Journal of Laryngology and Otology | 1994

Acute bilateral vocal fold paresis as a symptom of benign thyroid disease

Tomasz Kręcicki; Tadeusz Łukieńczuk; Maria Zalesska-Kręcicka; Waldemar Balcerzak

A case of bilateral laryngeal nerve paralysis caused by a small goitre is reported. After thyroidectomy the return of vocal fold movements was observed. A review of the literature is presented. The possibility of acute airway distress caused by a slightly enlarged goitre is emphasized.


Acta Oto-laryngologica | 1999

C-erbB-2 Immunostaining in Laryngeal Cancer

Tomasz Krecicki; Michał Jeleń; Maria Zalesska-Kręcicka

Tumour progression is strongly associated with a series of specific genetic changes in protooncogenes and tumour suppressor genes. One of the potential factors involved in tumorogenesis of squamous cell carcinomas is protooncogene c-erbB-2 (also known as neu or HER2). The authors analysed the expression of c-erbB-2 oncoprotein in 154 cases of laryngeal squamous cell carcinomas and its relationship to the clinical outcome of the patients. The difference in c-erbB-2 oncoprotein expression between the control group and cancer patients was on the statistical borderline (p = 0.0470). There was no significant correlation between c-erbB-2 expression and sex and age of the patients. T stage, lymph node status, site and histopathological grading of the tumour and clinical outcome of the patients. Univariate analysis revealed no correlation between c-erbB-2 expression and survival rates. We conclude that immunohistological examination of c-erbB-2 on paraffin section is not a valuable prognostic factor in laryngeal carcinoma.


Clinical Otolaryngology | 2001

Expression of type IV collagen and matrix metalloproteinase‐2 (type IV collagenase) in relation to nodal status in laryngeal cancer

Tomasz Krecicki; Maria Zalesska-Kręcicka; Michal Jelen; Teresa Szkudlarek; M. Horobiowska


Clinical Otolaryngology | 1998

Ki-67 immunostaining and prognosis in laryngeal cancer

Tomasz Krecicki; Michal Jelen; Maria Zalesska-Kręcicka; Teresa Szkudlarek


International Journal of Pediatric Otorhinolaryngology | 2005

Brain auditory evoked potentials in children with Down syndrome.

Tomasz Kręcicki; Maria Zalesska-Kręcicka; Krzysztof Kubiak; Wojciech Gawron


Auris Nasus Larynx | 2002

Quantitative evaluation of angiogenesis in laryngeal cancer by digital image measurement of the vessel density

Tomasz Kręcicki; Danuta Dus; Joanna Kozlak; Wojciech Tarnawski; Michal Jelen; Maria Zalesska-Kręcicka; Teresa Szkudlarek


Medical Science Monitor | 2006

Corticosteroid-induced laryngeal disorders in asthma

Tomasz Kręcicki; Jerzy Liebhart; Monika Morawska-Kochman; Ewa Liebhart; Maciej Zatoński; Maria Zalesska-Kręcicka

Collaboration


Dive into the Maria Zalesska-Kręcicka's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tomasz Krecicki

Wrocław Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Danuta Dus

Polish Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

J Rak

University of Wrocław

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jerzy Rak

University of Wrocław

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge